rimantadine has been researched along with Lung Diseases, Obstructive in 1 studies
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rimantadine was well-tolerated by the children, with no significant difference in reported adverse effects between the placebo and rimantadine groups." | 2.66 | Rimantadine prophylaxis in children: a follow-up study. ( Abell, TD; Clover, RD; Couch, RB; Crawford, SA; Glezen, P; Ramsey, CN, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crawford, SA | 1 |
| Clover, RD | 1 |
| Abell, TD | 1 |
| Ramsey, CN | 1 |
| Glezen, P | 1 |
| Couch, RB | 1 |
1 trial available for rimantadine and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Rimantadine prophylaxis in children: a follow-up study.
Topics: Adamantane; Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Metho | 1988 |